PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21056902-2	2011	Inhibition of guanylyl cyclase (GC) with either methylene blue or ODQ slightly inhibited the ability of submaximal concentrations of thrombin to increase [Ca(2+)](i) which suggests that a small portion of the thrombin mediated increase in [Ca(2+)](i) was due to an increase in NO and subsequent increase in cGMP and activation of cGMP dependent protein kinase (cGPK).	1H-(1,2,3)oxadiazolo(4,4-a)quinoxalin-1-one	66-69	coagulation factor II, thrombin	Homo sapiens	133-141	
21056902-5	2011	In platelets GEA3162 had no effect to increase [Ca(2+)](i) however it inhibited the ability of thrombin to increase [Ca(2+)](i) and this effect was reversed by ODQ.	1H-(1,2,3)oxadiazolo(4,4-a)quinoxalin-1-one	160-163	coagulation factor II, thrombin	Homo sapiens	95-103	
19895807-9	2010	In thrombin-activated platelets, ODQ fully prevented the SIN-1-induced cGMP elevations, but only partly prevented the adhesion inhibition.	1H-(1,2,3)oxadiazolo(4,4-a)quinoxalin-1-one	33-36	coagulation factor II, thrombin	Homo sapiens	3-11	
23144808-6	2012	RESULTS: BAY 60-2770 (0.001-10 microM) produced significant inhibition of collagen (2 microg/ml)- and thrombin (0.1 U/ml)-induced platelet aggregation that was markedly potentiated by the sGC inhibitor ODQ (10 microM).	1H-(1,2,3)oxadiazolo(4,4-a)quinoxalin-1-one	202-205	coagulation factor II, thrombin	Homo sapiens	102-110	
23144808-11	2012	Collagen- and thrombin-induced alpha(IIb)beta(3) activation was markedly inhibited by BAY 60-2770 that was further inhibited by ODQ.	1H-(1,2,3)oxadiazolo(4,4-a)quinoxalin-1-one	128-131	coagulation factor II, thrombin	Homo sapiens	14-22